Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels

被引:92
作者
Lin, Chih-Lin
Liao, Li-Ying
Liu, Chun-Jen
Yu, Ming-Whei
Chen, Pei-Jer
Lai, Ming-Yang
Chen, Ding-Shinn
Kao, Jia-Horng
机构
[1] Natl Taiwan Univ, Coll Med, Hepatitis Res Ctr, Taipei 100, Taiwan
[2] Natl Taiwan Univ, Coll Med, Dept Publ Hlth, Taipei 100, Taiwan
[3] Natl Taiwan Univ, Coll Med, Grad Inst Epidemiol, Taipei 100, Taiwan
[4] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 100, Taiwan
[5] Natl Taiwan Univ, Coll Med, Dept Med Res, Taipei 100, Taiwan
[6] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[7] Taipei City Hosp, Dept Gastroenterol, Ren Ai Branch, Taipei, Taiwan
关键词
D O I
10.1002/hep.21585
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Chronic hepatitis B patients with high-normal serum ALT (levels of 0.5-1 x upper limit of normal) are still at risk of liver disease progression. We thus investigated the correlation between serum ALT level and hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum ALT level (PNALT). Baseline clinical and virological features of 414 HBeAg-negative carriers, including 176 (42.5%) with low-normal ALT (levels of less than 0.5 x upper limit of normal) and 238 (57.5%) with high-normal ALT, were compared. Compared with HBV carriers with low-normal ALT, those with high-normal ALT were older (41 vs. 37 years, P < 0.001) and had a greater frequency of serum HBV DNA level > 10(4) copies/ml (63.4% vs. 47.5 %, P < 0.001) as well as a higher prevalence of basal core promoter T1762/A1764 mutant (36.5% vs. 24.2%, P = 0.01). Multivariate analysis showed that factors associated with a high-normal serum ALT level included male sex [odds ratio (OR), 1.82; 95% confidence interval (CI), 1.10-3.01, P = 0.019], increasing age (OR, < 30 years: 1, reference; 30-39 years: 2.43, 95% CI, 1.18-5.03, P = 0.016; 40-49 years: 4.22, 95% CI, 1.99-8.93, P < 0.001; >= 50 years: 4.06, 95% CI, 1.69-9.78, P = 0.002) and serum HBV DNA level > 10(4) copies/ml (OR, 1.83; 95% CI, 1.07-3-13, P = 0.027). Conclusion: HBeAg-negative patients with persistently normal ALT are not a homogenous group, and those with high-normal ALT share some of the characteristics that have been associated with adverse long-term outcomes.
引用
收藏
页码:1193 / 1198
页数:6
相关论文
共 28 条
[1]
Chronic hepatitis B e antigen (HBeAg) negative, anti-HBe positive hepatitis B: an overview [J].
Bonino, F ;
Brunetto, MR .
JOURNAL OF HEPATOLOGY, 2003, 39 :S160-S163
[2]
Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study [J].
Brunetto, MR ;
Oliveri, F ;
Coco, B ;
Leandro, G ;
Colombatto, P ;
Gorin, JM ;
Bonino, F .
JOURNAL OF HEPATOLOGY, 2002, 36 (02) :263-270
[3]
Chan HLY, 2002, AM J GASTROENTEROL, V97, P406
[4]
High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases [J].
Chen, BF ;
Liu, CJ ;
Jow, GM ;
Chen, PJ ;
Kao, JH ;
Chen, DS .
GASTROENTEROLOGY, 2006, 130 (04) :1153-1168
[5]
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level [J].
Chen, CJ ;
Yang, HI ;
Su, J ;
Jen, CL ;
You, SL ;
Lu, SN ;
Huang, GT ;
Iloeje, UH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (01) :65-73
[6]
Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection [J].
Chu, CJ ;
Hussain, M ;
Lok, ASF .
HEPATOLOGY, 2002, 36 (06) :1408-1415
[7]
NATURAL-HISTORY OF CHRONIC HEPATITIS-B VIRUS-INFECTION IN TAIWAN - STUDIES OF HEPATITIS-B VIRUS-DNA IN SERUM [J].
CHU, CM ;
KARAYIANNIS, P ;
FOWLER, MJF ;
MONJARDINO, J ;
LIAW, YF ;
THOMAS, HC .
HEPATOLOGY, 1985, 5 (03) :431-434
[8]
Geier A, 2002, NEW ENGL J MED, V347, P1721
[9]
Clinical evaluation and applications of the Amplicor HBV Monitor™ test, a quantitative HBV DNA PCR assay [J].
Gerken, G ;
Gomes, J ;
Lampertico, P ;
Colombo, M ;
Rothaar, T ;
Trippler, M ;
Colucci, G .
JOURNAL OF VIROLOGICAL METHODS, 1998, 74 (02) :155-165
[10]
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load [J].
Iloeje, UH ;
Yang, HI ;
Su, J ;
Jen, CL ;
You, SL ;
Chen, CJ .
GASTROENTEROLOGY, 2006, 130 (03) :678-686